Relevance of specific immunoglobulin M and immunoglobulin G for parvovirus B19 diagnosis in patients with acute lymphoblastic leukemia receiving chemotherapy: Prospective study

Archives of Pathology and Laboratory Medicine

Volumn 131, Issue 11, 2007, Pages 1697-1699

  Zaki, Maysaa El Sayed ^a  

^a MANSOURA UNIVERSITY   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M; IMMUNOGLOBULIN M ANTIBODY; VIRUS DNA;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ANTIBODY DETECTION; ARTICLE; BONE MARROW BIOPSY; BONE MARROW CELL; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; DNA DETERMINATION; FEMALE; HUMAN; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNOCOMPROMISED PATIENT; LABORATORY DIAGNOSIS; MALE; PARVOVIRUS; POLYMERASE CHAIN REACTION; SCHOOL CHILD; SERODIAGNOSIS; VIREMIA; VIRUS DIAGNOSIS;

ANTINEOPLASTIC AGENTS; BONE MARROW; CASE-CONTROL STUDIES; CHILD; DNA, VIRAL; ERYTHEMA INFECTIOSUM; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MALE; PARVOVIRUS B19, HUMAN; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROSPECTIVE STUDIES;

EID: 35949000790     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Berns KI. Parvoviridae: the viruses and their replication. In: Fields BN, Knipe DM, Howley PM, et al, eds. Fields Virology. Philadelphia, Pa: Lippincott-Raven; 1996:2173-2197.
2. Brown KE, Anderson SM, Young NS. Erythrocyte P antigen cellular receptor of parvovirus B19. Science. 1993;268:114-117.
3. Anderson LJ. Human parvovirus B19. In: Richman DD, Whitley JR, Hayden FG, eds. Clinical Virology. Washington, DC: ASSN Press; 2002:2036-2094.
4. Ashan N, Holman MJ, Gocke CD, et al. Pure red cell aplasia due to parvovirus B19 infection in solid organ transplantation. Clin Transplant. 1997;11:265-270.
5. Chermak E, Dubin G, Henry D, et al. Infection due to parvovirus B19 in patients with human immunodeficiency virus. Clin Infect Dis. 1995;20:170-173.
6. Hartmann JT, Meisinger I, Krober SM, Weisel K, Klingel K, Kanz L. Progressive bicytopenia due to persistent parvovirus B19 infection after immunochemotherapy with fludarabine/cyctophosphamide and rituximab for relapsed B cell lymphoma. Haematologica. 2006;91(12 suppl):ECR 49.
7. Rao SP, Miller ST, Cohen BJ. B19 parvovirus infection in children with malignant solid tumors receiving chemotherapy. Med Pediat Oncol. 1994;22:255-257.
8. Kerr JR, Barah F, Smith J, et al. Association of acute parvovirus B19 infection with new onset of acute lymphoblastic and myeloblastic leukaemia. J Clin Pathol. 2003;56:873-875.
9. Savasan S, Ozdeir O. Parvovirus B19 infection and acute lymphoblastic leukaemia. Br J Hematol. 2003;120:166-171.
10. Isa A, Norbeck O, Hirbod T, et al. Aherrant cellular immune responses in humans infected persistently with parvovirus B19. J Med Virol. 2006;78:129-133.
11. Ros C, Gerber M, Kempf C. Conformational changes in the VP1-unique region of native human parvovirus B19 lead to exposure of internal sequences that play a role in virus neutralization and infectivity. J Virol. 2006;80:12017-12024.
12. Modarows S, Dorsch S. Antibody responses in parvovirus B19 infected patients. Pathol Biol. 2002;50:326-331.
13. Cassinotti P, Burtonboy G, Fopp M, et al. Evidence for persistence of human parvovirus B19 DNA in bone marrow. J Med Virol. 1997;53:229-232.
14. Clewley JP. Polymerase chain reaction assay of parvovirus B19 DNA in clinical specimens. J Clin Microbiol. 1989;27:2647-2651.
15. Zaki ME, Hassan SA, Seleim T, Lateef RA. Parvovirus B19 infection in children with a variety of hematological disorders. Hematology. 2006;11:261-266.
16. Brown KE. Variants of B19. Dev Biol (Basel). 2004;118:71.
17. Gallinella G, Zuffi E, Gentilomi G, et al. Relevance of B19 markers in serum samples for a diagnosis of parvovirus B19-correlated diseases. J Med Virol. 2003;71:135-139.
18. Flunker G, Peters A, Wiersbitzky S, Modrow S, Seidel W. Persistent parvovirus B19 infections in immunocompromised children. Med Microbiol Immunol (Berl). 1998;186:189-194.
19. Beersma MF, Claas EC, Sopaheluakan T, Kroes AC. Parvovirus B19 viral loads in relation to VP1 and VP2 antibody responses in diagnostic blood samples. J Clin Virol. 2005;34:71-75.
20. Sabella C, Goldfarb J. Parvovirus B19 infections. Am Fam Physician. 1999;60:1455-1460.